Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,963 public trials 2,020 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Pirtobrutinib With Rituximab in Patients With Mantle Cell Lymphoma

NCT07285590

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Instituto Português de Oncologia de Lisboa Francisco Gentil Lisbon, Lisbon District, Portugal
  • Unidade Local De Saude De Santa Maria E.P.E. Lisbon, Lisbon District, Portugal
  • INSTITUT CATALÀ D'ONCOLOGIA (ICO). Hospital Germans Trias I Pujol. Badalona, Barcelona, Spain
  • Hospital Universitari Vall d'Hebron Barcelona, Spain
View all 16 locations
View Trial Details
Recruiting

A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma

NCT07189065

Conditions
Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Anhui Cancer Hospital (West Branch of Anhui Provincial Hospital) Hefei, Anhui, China
  • Beijing Shijitan Hospital Beijing, Beijing Municipality, China
  • Beijing Tongren Hospital Beijing, Beijing Municipality, China
  • National Cancer Center/Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
View all 41 locations
View Trial Details
Recruiting

Amping up With PemJAK

NCT07283822

Conditions
Cutaneous T-Cell Lymphomas, Gray Zone Lymphoma, Hemic and Lymphatic Diseases, +17 more
Locations
  • Columbia University Irving Medical Center New York, United States
View Trial Details
Recruiting

Mosunetuzumab for CLL MRD Clearance

NCT07052695

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Brigham & Women's Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions